Liz Parrish, Patient Zero: First gene therapy to treat biological aging
According to the Longevity Impact Forum, Patient Zero has proven that Longevity Technology number one is a patient-tested technology.
Liz Parrish CEO of BioViva, USA. A short clip from the gene therapy she underwent in 2015 to fight biological aging. This is the first step in curing diseases such as Alzheimer’s, heart disease and kidney failure. We could save 8 billion people by working quickly to achieve this goal.
https://www.BioViva-Science.com
https://www.Integrated-Health-Systems.com
Join us on Facebook, Twitter, Google+, YouTube, and Subscribe to our blog.
https://www.linkedin.com/in/liz-parrish-73870629/
https://www.facebook.com/BiovivaSciences/
Tweets from BioVivaScience
https://www.instagram.com/biovivasciences/
#disruptaging #genetherapy #genomiccounseling #biovivascience #genome #senescence #aging #longevity
Source:
